Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $171.8 million.

  • Icu Medical's Accounts Payables rose 189.25% to $171.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.8 million, marking a year-over-year increase of 189.25%. This contributed to the annual value of $148.0 million for FY2024, which is 133.97% down from last year.
  • According to the latest figures from Q3 2025, Icu Medical's Accounts Payables is $171.8 million, which was up 189.25% from $168.8 million recorded in Q2 2025.
  • Icu Medical's 5-year Accounts Payables high stood at $215.9 million for Q4 2022, and its period low was $62.0 million during Q3 2021.
  • In the last 5 years, Icu Medical's Accounts Payables had a median value of $167.1 million in 2023 and averaged $153.1 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first crashed by 3099.57% in 2021, then skyrocketed by 23067.02% in 2022.
  • Icu Medical's Accounts Payables (Quarter) stood at $81.1 million in 2021, then surged by 166.13% to $215.9 million in 2022, then plummeted by 30.51% to $150.0 million in 2023, then decreased by 1.34% to $148.0 million in 2024, then increased by 16.03% to $171.8 million in 2025.
  • Its last three reported values are $171.8 million in Q3 2025, $168.8 million for Q2 2025, and $180.4 million during Q1 2025.